Information Letter on Buccolam®: Recall due to a potential quality defect
2014.10.09
Active substance: midazolam
The company ViroPharma GmbH issues information on the recall of the medicinal product Buccolam®. During a routine inspection at the manufacturing site, the potential risk of a cross-contamination with another medicinal product produced at the same site was discovered.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN